Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Novavax, Inc. shares valued at $95,331 were purchased by Dubovsky Filip on Sep 18 ’24. At $13.00 per share, Dubovsky Filip acquired 7,335 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, YOUNG JAMES F sold 7,500 shares, netting a total of over 105,675 in proceeds. Following the sale of shares at $14.09 each, the insider now holds 61,760 shares.
Before that, YOUNG JAMES F had sold 7,500 shares from its account. In a trade valued at $102,881, the Director traded Novavax, Inc. shares for $13.72 each. Upon closing the transaction, the insider’s holdings decreased to 7,500 shares, worth approximately $0.89 million.
As published in a research note from JP Morgan on July 30, 2024, Novavax, Inc. [NVAX] has been rated down from a Neutral to an Underweight and the price target has been revised to $8. Analysts at JP Morgan upgraded the stock from ‘”an Underweight”‘ to ‘”a Neutral”‘ outlook in a report released in early May. As of May 10, 2024, BofA Securities has increased its “an Underperform” rating to a “Neutral” for NVAX. Earlier on August 09, 2023, B. Riley Securities upgraded its rating. Their new recommendation was “a Buy” for NVAX stock which previously was a “a Neutral”.
Analyzing NVAX Stock Performance
During the last five days, there has been a drop of approximately -10.51%. Over the course of the year, Novavax, Inc. shares have jumped approximately 168.85%. Shares of the company reached a 52-week high of $23.86 on 06/06/24 and a 52-week low of $3.53 on 02/05/24. A 50-day SMA is recorded $12.46, while a 200-day SMA reached $9.35. Nevertheless, trading volume fell to 4.46 million shares from 6.06 million shares the previous day.
Support And Resistance Levels for Novavax, Inc. (NVAX)
According to the 24-hour chart, there is a support level at 12.56, which, if violated, would cause prices to drop to 12.22. In the upper region, resistance lies at 13.29. The next price resistance is at 13.67. RSI (Relative Strength Index) is 49.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.19, which suggests the price will decrease in the coming days. Percent R is at 65.95%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
